These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24987404)

  • 21. Comparison of the use of screening tools for evaluating cognitive impairment in patients with Parkinson's disease.
    Camargo CHF; Tolentino ES; Bronzini A; Ladeira MA; Lima R; Schultz-Pereira GL; Young-Blood MR
    Dement Neuropsychol; 2016; 10(4):344-350. PubMed ID: 29213480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Test the Best: Classification Accuracies of Four Cognitive Rating Scales for Parkinson's Disease Mild Cognitive Impairment.
    Mazancova AF; Růžička E; Jech R; Bezdicek O
    Arch Clin Neuropsychol; 2020 Oct; 35(7):1069–1077. PubMed ID: 32681175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease.
    Ben Sassi S; Nabli F; Hentati E; Nahdi H; Trabelsi M; Ben Ayed H; Amouri R; Duda JE; Farrer MJ; Hentati F
    Parkinsonism Relat Disord; 2012 Mar; 18(3):243-6. PubMed ID: 22056842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficit in specific cognitive domains associated with dementia in Parkinson's disease.
    Pal A; Pegwal N; Kaur S; Mehta N; Behari M; Sharma R
    J Clin Neurosci; 2018 Nov; 57():116-120. PubMed ID: 30150061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White matter damage in patients with mild cognitive impairment in Parkinson's disease.
    Li QQ; Wu K; Xu JL; Yin L
    Quant Imaging Med Surg; 2022 Feb; 12(2):1290-1298. PubMed ID: 35111624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
    Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
    Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Mini-Mental State Examination and Montreal Cognitive Assessment executive subtests in detecting post-stroke cognitive impairment.
    Fu C; Jin X; Chen B; Xue F; Niu H; Guo R; Chen Z; Zheng H; Wang L; Zhang Y
    Geriatr Gerontol Int; 2017 Dec; 17(12):2329-2335. PubMed ID: 28675607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Montreal Cognitive Assessment Predicts the Short-Term Risk of Lewy Body Disease in Isolated REM Sleep Behavior Disorder with Reduced MIBG Scintigraphy.
    Miyamoto M; Miyamoto T
    Mov Disord Clin Pract; 2023 Jan; 10(1):32-41. PubMed ID: 36698993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cut-off points of the Portuguese version of the Montreal Cognitive Assessment for cognitive evaluation in Parkinson's disease.
    Almeida KJ; Carvalho LCLS; Monteiro THOH; Gonçalves PCJ; Campos-Sousa RN
    Dement Neuropsychol; 2019; 13(2):210-215. PubMed ID: 31285796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease.
    Chen L; Yu C; Fu X; Liu W; Hua P; Zhang N; Kuo S
    Shanghai Arch Psychiatry; 2013 Oct; 25(5):296-305. PubMed ID: 24991170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suitability of the Montreal cognitive assessment versus the mini-mental state examination in detecting vascular cognitive impairment.
    Ihara M; Okamoto Y; Takahashi R
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):737-41. PubMed ID: 22306380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of repetitive transcranial magnetic stimulation on cognitive impairment in Parkinson's disease with dementia: Pilot study.
    Khedr EM; Mohamed KO; Ali AM; Hasan AM
    Restor Neurol Neurosci; 2020; 38(1):55-66. PubMed ID: 31815705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease.
    Yang J; Pourzinal D; Byrne GJ; McMahon KL; Copland DA; O'Sullivan JD; Mitchell L; Dissanayaka NN
    Int J Geriatr Psychiatry; 2023 Jun; 38(6):e5955. PubMed ID: 37318156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological profile in Chinese patients with Parkinson's disease and normal global cognition according to Mini-Mental State Examination Score.
    Qiao J; Zheng X; Wang X; Lu W; Cao H; Qin X
    Int J Clin Exp Med; 2015; 8(8):13755-61. PubMed ID: 26550322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination.
    Vásquez KA; Valverde EM; Aguilar DV; Gabarain HH
    Dement Neuropsychol; 2019; 13(1):78-81. PubMed ID: 31073382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a Brief Cognitive Screening Tool for Predicting Postoperative Delirium in Patients with Parkinson's Disease: A Secondary Analysis.
    Zhou Y; Wang X; Li Z; Ma Y; Yu C; Chen Y; Ding J; Yu J; Zhou R; Yang N; Liu T; Guo X; Fan T; Shi C
    Clin Interv Aging; 2023; 18():1555-1564. PubMed ID: 37727451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.